Возраст домена | 11 лет |
Дата окончания | Истек срок регистрации |
PR | 5 |
ИКС | n/a |
Страниц в Google | 424 |
Страниц в Яндексе | 58 |
Dmoz | Нет |
Яндекс Каталог | Нет |
Alexa Traffic Rank | 3087531 |
Alexa Country | Нет данных |
История изменения показателей | Авторизация |
Идет сбор информации... Обновить
EASD Industry | Programme, Meet-the-Expert Sessions & Sponsors
n/a
Industry Programme for the 54nd Annual Meeting of the European Association for the Study of Diabetes 2018 in Berlin, Germany.
UTF-8
58.39 КБ
571
4 613 симв.
3 899 симв.
Данные предоставлены сервисом semrush
Сайт | Общие фразы | PR | тИЦ | Alexa Rank | Alexa Country | |
---|---|---|---|---|---|---|
![]() |
11 | 6 |
30 | 385412 | ![]() | |
![]() ![]() |
8 | 7 |
0 | 2705 | ![]() | |
![]() |
8 | 5 |
10 | 8011293 | ![]() |
|
![]() ![]() |
7 | 8 |
0 | 113 | ![]() | |
![]() |
7 | 5 |
0 | 5434752 | ![]() |
|
![]() ![]() |
7 | 7 |
70 | 33720 | ![]() | |
![]() ![]() |
7 | 6 |
0 | 30882 | ![]() | |
![]() ![]() |
6 | 6 |
0 | 6906980 | ![]() |
|
![]() ![]() |
4 | 6 |
110 | 185049 | ![]() | |
![]() |
4 | 4 |
0 | Нет данных | ![]() |
|
Еще 37 сайтов после авторизации |
Данные предоставлены сервисом semrush
Счетчик | Посетители за 24 часа | Просмотры | Просмотров на посетителя |
---|---|---|---|
![]() | Нет доступа | Нет доступа | n/a |
Данные linkpad ( 4 Октября 2016 ) | |
Количество ссылок на сайт | 93 |
Количество доменов, которые ссылаются на сайт | 33 |
Количество найденных анкоров | 17 |
Исходящие (внешние) ссылки домена | 134 |
Количество доменов, на которые ссылается сайт | 26 |
Количество исходящих анкоров | 24 |
Внешние ссылки главной страницы ( 2 ) | |
delegate-services.com/events/external-novo-nordisk-symposia-... | Please register here |
exhibition.interplan.de/inhalt/uploads/2018/10/EASD19_Overvi... | Download (PDF) |
Внутренние ссылки главной страницы ( 44 ) | |
# | - |
/symposia-programme | All Symposia |
/meet-the-expert-session | All MTE Sessions |
/speakers | All Speakers |
/sponsors | All Sponsors |
/speaker/richard-gilbert | Richard Gilbert |
/speaker/richard-bergenstal | Richard Bergenstal |
/speaker/robert-ritzel | Robert Ritzel |
/speaker/david-dejonghe | David DeJonghe |
/speaker/david-russell-jones | David Russell-Jones |
/speaker/vivian-fonseca | Vivian Fonseca |
/speaker/rolf-hinzmann | Rolf Hinzmann |
/speaker/melanie-davies | Melanie Davies |
/speaker/ralph-defronzo | Ralph DeFronzo |
/speaker/martin-cowie | Martin Cowie |
/programme/changing-diabetes-care-from-glycaemia-to-cardiova... | Glycaemic control and beyond: shifting the paradigm in diabetes care |
/programme/illuminating-the-path-of-care-for-a-complex-disea... | Illuminating the path of care for a multifaceted disease |
/programme/tomorrows-management-of-diabetes-today | Tomorrow’s management of diabetes, today |
/programme/improving-outcomes-in-type-2-diabetes-focus-on-ca... | Improving Outcomes in Type 2 Diabetes: Focus on Cardiovascular and Renal |
/programme/behind-insulin-resistance-debugging-the-endocrine... | Behind insulin resistance: debugging the endocrine system |
/programme/coffee-and-diabetes | Coffee and type 2 diabetes: A review of the latest research |
/programme/innovation-within-insulin-management-of-type-1-di... | Innovation within insulin management of type 1 diabetes |
/programme/fighting-the-pre-diabetes-pandemic | Fighting the pre-diabetes pandemic |
/programme/overcoming-the-challenges-of-weight-management-in... | Overcoming the challenges of weight management in clinical practice |
/programme/the-future-of-connected-self-monitoring-of-blood-... | THE FUTURE OF CONNECTED SELF MONITORING OF BLOOD GLUCOSE |
/programme/new-insights-for-clinician-choices-in-the-treatme... | New Insights for Clinician Choices in the Treatment of Patients with Type 2 Diabetes |
/programme/advances-in-insulin-therapies-when-and-how-to-use... | Advances in Insulin Therapies: When and How to Use Them |
/mte/variability-or-hypoglycaemia-what-is-most-important | 10:30 - 11:00Networking HubVariability or hypoglycaemia: what is most important?Hans de VriesSimoen Heller |
/mte/glucose-lowering-drugs-and-cardiovascular-protection-an... | 11:30 - 12:00Networking HubGlucose-lowering drugs and cardiovascular protection: an added benefit or a primary factor in the typ... |
/mte/ertugliflozin-a-newly-emerging-sglt2-inhibitor-for-pati... | 13:00-13:30Networking HubErtugliflozin – A Newly Emerging SGLT2 Inhibitor for Patients with Type 2 DiabetesSam Dagogo-Jack |
/mte/the-bright-study-the-first-head-to-head-comparison-of-s... | 14:00-14:30Networking HubThe BRIGHT study, the first head-to-head comparison of second-generation basal insulin analogs Alice Ch... |
/mte/do-we-need-to-have-a-paradigm-shift-in-type-1-diabates | 11:30-12:00Networking HubDo we need to have a paradigm shift in Type 1 Diabates?Thomas DanneParth Narendran |
/mte/kissin-insulin-management-keep-it-short-simple-with-the... | 13:00-13:30Networking Hub‘KISSin‘ Insulin Management: Keep It Short & Simple with the Latest Titration Tools"Steven Edelman |
/mte/sglt2-inhibitor-cradiovascular-and-renal-effects-puttin... | 14:00-14:30Networking HubSGLT2 - Inhibitor cradiovascular and renal effects - putting the pieces of the puzzle togetherFrancesco... |
/mte/cvd-real-insights-from-current-clinical-practice | 10:30-11:00Networking HubCVD-Real: insights from current clinical practiceKamlesh Khunti Mikhail Kosiborod |
/mte/leptin-replacement-experience-in-lipodystrophy-case-dis... | 11:30-12:00Networking HubHow to treat LipodystrophyGiovanni Ceccarini |
/mte/improving-glucose-control-in-type-1-diabetes-the-role-o... | 13:00-13:30Networking HubImproving glucose control in type 1 diabetes: The role of non-insulin pathwaysJeremy Pettus |
/mte/how-to-treat-lipodystrophy | 14:00-14:30Networking HubHow to treat LipodystrophyMichael Stumvoll |
/sponsors/mdbriefcase-group | mdBriefCase GroupThis is some text inside of a div block.SymposiaMTE SessionExhibition |
/sponsors/vibrosense-dynamics | VibroSense DynamicsThis is some text inside of a div block.SymposiaMTE SessionExhibition |
/sponsors/medexel-co-ltd | MEDEXEL CO., LTD.This is some text inside of a div block.SymposiaMTE SessionExhibition |
/sponsors/sd-biosensor-inc | SD Biosensor Inc.This is some text inside of a div block.SymposiaMTE SessionExhibition |
/legal | Legal Notice |
/data-protection | Data Protection |
Domain Name: EASD-INDUSTRY.COM
Registry Domain ID: 1747305611_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.meshdigital.com
Registrar URL: http://www.meshdigital.com
Updated Date: 2017-08-08T13:30:52Z
Creation Date: 2012-09-24T11:31:15Z
Registry Expiry Date: 2017-09-24T11:31:15Z
Registrar: Mesh Digital Limited
Registrar IANA ID: 1390
Registrar Abuse Contact Email:
Registrar Abuse Contact Phone:
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS.NAMESPACE4YOU.DE
Name Server: NS2.NAMESPACE4YOU.DE
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2017-09-20T17:35:06Z <<<
For more information on Whois status codes, please visit https://icann.org/epp
NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.
TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.
The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.
ФРГ - Кёльн - 84.19.28.94
comtrance GmbH
comtrance GmbH
HTTP/1.1 200 OK
Server: openresty
Date: Mon, 14 Jan 2019 10:30:53 GMT
Content-Type: text/html
Content-Length: 59795
Connection: keep-alive
x-lambda-id: b7ba4581-9d35-40c5-948a-65c14ca55354
Via: 1.1 varnish
Accept-Ranges: bytes
Via: 1.1 varnish
Age: 48748
X-Served-By: cache-iad2129-IAD, cache-bwi5046-BWI
X-Cache: HIT, HIT
X-Cache-Hits: 1, 1
X-Timer: S1547461854.622079,VS0,VE2
Vary: Accept-Encoding
Кнопка для анализа сайта в один клик, для установки перетащите ссылку на "Панель закладок"